HGERS
CLDI icon

Householder Group Estate & Retirement Specialist’s Calidi Biotherapeutics CLDI Stock Holding History

Householder Group Estate & Retirement Specialist’s Portfolio CLDI Stock Details CLDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3
Closed – – 657
2024
Q3 		$0 Buy
+3
New +$835 ﹤0.01% 1184

Other funds holding CLDI

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
CI
CPR Investments Rochester, Michigan $130M AUM 29.56% 1-Year Est. Return
DWM
Drive Wealth Management Lehi, Utah $561M AUM 33.14% 1-Year Est. Return
RWI
Red Wave Investments Dillsburg, Pennsylvania $335M AUM 15.13% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCI
RS Crum Inc Newport Beach, California $517M AUM 16.68% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Householder Group Estate & Retirement Specialist's CLDI Position: Q4 2024 in Review

Householder Group Estate & Retirement Specialist sold out of Calidi Biotherapeutics (CLDI) in Q4 2024, closing a stake of 3 shares.

Householder Group Estate & Retirement Specialist first reported a position in CLDI in Q3 2024 and held it in 1 quarter. The position peaked at $0 in Q3 2024. 33 funds tracked by Wall St. Rank hold CLDI as of Q4 2024.

  • Householder Group Estate & Retirement Specialist reported no remaining Calidi Biotherapeutics position as of Q4 2024 after selling out during the quarter.
  • Householder Group Estate & Retirement Specialist sold 3 Calidi Biotherapeutics shares in Q4 2024.
  • Householder Group Estate & Retirement Specialist first reported a position in Calidi Biotherapeutics in Q3 2024 and held it in 1 quarter.
  • Householder Group Estate & Retirement Specialist's Calidi Biotherapeutics position peaked at $0 in Q3 2024.
  • 33 funds tracked by Wall St. Rank held Calidi Biotherapeutics as of Q4 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2024, filed 15 Jan 2025.